Clinical trial
The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients
NCT00114556 · Royal Prince Alfred Hospital, Sydney, Australia, Other · Completed
Key facts
| NCT number | NCT00114556 |
|---|---|
| Title | The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients |
| Official title | The Effect Of The Bisphosphonate, Zoledronic Acid, On Bone Density In Liver Transplant Patients - A Prospective, Randomised, Controlled Clinical Trial |
| Lead sponsor | Royal Prince Alfred Hospital, Sydney, Australia, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteoporosis, Liver Transplantation, Fractures |
| Intervention type | Drug |
| Interventions | zoledronic acid |
| Enrollment | 100 |
| Start date | Feb 1, 2000 |
| Completion | Aug 1, 2004 |
| First posted | Jun 16, 2005 |
| Last update posted | May 9, 2006 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: